Statement of Ownership (sc 13g)
July 14 2022 - 5:27PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No.)*
| BioRestorative Therapies, Inc. |
| (Name of Issuer) |
| |
| Common Stock, $0.0001 par value |
| (Title of Class of Securities) |
| |
| 090655606 |
| (CUSIP Number) |
| |
| June 30, 2022 |
| (Date of Event Which Requires Filing of this Statement) |
Check the appropriate box to designate
the rule pursuant to which this Schedule is filed:
| o |
Rule 13d-1(b) |
| x |
Rule 13d-1(c) |
| o |
Rule 13d-1(d) |
*The remainder of this cover page shall be
filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for
any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder
of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of
1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).
| CUSIP No. 090655606 | 13G | Page 1 of 8 Pages |
|
1. |
NAME OF REPORTING PERSONS
Auctus Fund, LLC
|
|
2. |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(SEE INSTRUCTIONS)
(a) o
(b) o |
|
3. |
SEC USE ONLY
|
|
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH |
5. |
SOLE VOTING POWER
0
|
|
6. |
SHARED VOTING POWER
210,000
|
|
7. |
SOLE DISPOSITIVE POWER
0
|
|
8.
|
SHARED DISPOSITIVE POWER
210,000
|
|
9. |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
210,000
|
|
10. |
CHECK IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS)
o |
|
11. |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.8% (See Note 1)
|
|
12.
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
|
| |
|
|
|
| (1) | Based on 3,637,219 outstanding shares of Common Stock as of May 9, 2022, as represented by the Issuer in the 10Q filed
with the Securities and Exchange Commission on May 16, 2022. |
| CUSIP No. 090655606 | 13G | Page 2 of 8 Pages |
|
1. |
NAME OF REPORTING PERSONS
Auctus Fund Management LLC
|
|
2. |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(SEE INSTRUCTIONS)
(a) o
(b) o |
|
3. |
SEC USE ONLY
|
|
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH |
5. |
SOLE VOTING POWER
0
|
|
6. |
SHARED VOTING POWER
210,000
|
|
7. |
SOLE DISPOSITIVE POWER
0
|
|
8.
|
SHARED DISPOSITIVE POWER
210,000
|
|
9. |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
210,000
|
|
10. |
CHECK IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS)
o |
|
11. |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.8% (See Note 2)
|
|
12.
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IA, OO, HC
|
| |
|
|
|
| CUSIP No. 090655606 | 13G | Page 3 of 8 Pages |
|
1. |
NAME OF REPORTING PERSONS
Alfred Sollami
|
|
2. |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(SEE INSTRUCTIONS)
(a) o
(b) o
|
|
3. |
SEC USE ONLY
|
|
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH |
5. |
SOLE VOTING POWER
0
|
|
6. |
SHARED VOTING POWER
210,000
|
|
7. |
SOLE DISPOSITIVE POWER
0
|
|
8.
|
SHARED DISPOSITIVE POWER
210,000
|
|
9. |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
210,000
|
|
10. |
CHECK IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS)
o
|
|
11. |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.8% (See Note 3)
|
|
12.
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN, HC
|
| |
|
|
|
(3) See Note (1) Above
| CUSIP No. 090655606 | 13G | Page 4 of 8 Pages |
|
1. |
NAME OF REPORTING PERSONS
Louis Posner
|
|
2. |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(SEE INSTRUCTIONS)
(a) o
(b) o
|
|
3. |
SEC USE ONLY
|
|
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH |
5. |
SOLE VOTING POWER
0
|
|
6. |
SHARED VOTING POWER
210,000
|
|
7. |
SOLE DISPOSITIVE POWER
0
|
|
8.
|
SHARED DISPOSITIVE POWER
210,000
|
|
9. |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
210,000
|
|
10. |
CHECK IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS)
o
|
|
11. |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.8% (See Note 4)
|
|
12.
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN, HC
|
| |
|
|
|
(4) See Note (1) Above
| CUSIP No. 090655606 | 13G | Page 5 of 8 Pages |
| Item 1(a). | Name of Issuer: |
BioRestorative Therapies, Inc. (the “Issuer”)
| Item 1(b). | Address of Issuer’s Principal Executive Offices: |
40 Marcus Drive
Melville, New York 11747
| Item 2(a). | Name of Persons Filing: |
This
statement is filed by the entities and persons listed below, who are collectively referred to herein as "Reporting Persons",
with respect to the shares of Common Stock of the Company:
| (ii) | Auctus Fund Management LLC |
| Item 2(b). | Address of Principal Business Office or, if none, Residence: |
545 Boylston Street, Suite 200
Boston, MA 02116
| (ii) | Auctus Fund Management LLC |
545 Boylston Street, Suite 200
Boston, MA 02116
545 Boylston Street, Suite 200
Boston, MA 02116
545 Boylston Street, Suite 200
Boston, MA 02116
| (ii) | Auctus Fund Management LLC – DE |
| (iii) | Alfred Sollami – USA |
| Item 2(d). | Title of Class of Securities: |
Common Stock, par value $0.0001 par value (“Common Stock”)
090655606
| Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check
whether the person filing is a: |
Not Applicable
| (a) | Amount beneficially owned: 210,000 (See Note 5) |
| (b) | Percent of class: 5.8% (See Note 6) |
| (c) | Number of shares as to which the person has: |
| (i) | Sole power to vote or to direct the vote: 0 |
| (ii) | Shared power to vote or to direct the vote: 210,000 (See
Note 5) |
| (iii) | Sole power to dispose or to direct the disposition of:
0 |
| (iv) | Shared power to dispose or to direct the disposition
of: 210,000 (See Note 5) |
| (ii) | Auctus Fund Management LLC |
| (a) | Amount beneficially owned: 210,000 (See Note 5) |
| (b) | Percent of class: 5.8% (See Note 6) |
| (c) | Number of shares as to which the person has: |
| (i) | Sole power to vote or to direct the vote: 0 |
| (ii) | Shared power to vote or to direct the vote: 210,000 (See
Note 5) |
| (iii) | Sole power to dispose or to direct the disposition of:
0 |
| (iv) | Shared power to dispose or to direct the disposition
of: 210,000 (See Note 5) |
| (a) | Amount beneficially owned: 210,000 (See Note 5) |
| (b) | Percent of class: 5.8% (See Note 6) |
| (c) | Number of shares as to which the person has: |
| (i) | Sole power to vote or to direct the vote: 0 |
| (ii) | Shared power to vote or to direct the vote: 210,000 (See
Note 5) |
| (iii) | Sole power to dispose or to direct the disposition of:
0 |
| (iv) | Shared power to dispose or to direct the disposition
of: 210,000 (See Note 5) |
| (a) | Amount beneficially owned: 210,000 (See Note 5) |
| (b) | Percent of class: 5.8% (See Note 6) |
| (c) | Number of shares as to which the person has: |
| (i) | Sole power to vote or to direct the vote: 0 |
| (ii) | Shared power to vote or to direct the vote: 210,000 (See
Note 5) |
| (iii) | Sole power to dispose or to direct the disposition of:
0 |
| (iv) | Shared power to dispose or to direct the disposition
of: 210,000 (See Note 5) |
| CUSIP No. 090655606 | 13G | Page 6 of 8 Pages |
Note 5:
Auctus Fund Management LLC is an exempt reporting adviser that files annual reports with the SEC and the state of Massachusetts and serves as the investment manager to Auctus Fund, LLC, (the "Fund"). Mr. Alfred Sollami and Mr. Louis Posner, as Managing Members of Auctus Fund Management LLC, with the power to exercise investment and voting discretion, may be deemed to be the beneficial owners of all shares of Common Stock held by the Fund. Pursuant to Rule 13d-4 under the Securities Exchange Act of 1934, as amended, the Fund expressly disclaims beneficial ownership over any of the securities reported in this statement, and the filing of this statement shall not be construed as an admission that the Fund is the beneficial owner of any of the securities reported herein.
Note 6:
Based on 3,637,219 outstanding shares of Common Stock as of May 9, 2022, as represented by the Issuer in the 10Q filed
with the Securities and Exchange Commission on May 16, 2022.
| Item 5. |
Ownership of Five Percent or Less of
a Class:
Not Applicable
|
| Item 6. |
Ownership of More Than Five Percent on Behalf of Another
Person:
|
| |
See Note 5 above. The Fund has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the
sale of, the shares of Common Stock covered by this Statement. |
| Item 7. |
Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent Holding Company:
|
| |
See Note 5 above |
| Item 8. |
Identification and Classification of Members of the Group: |
| |
Not Applicable
|
| Item 9. |
Notice of Dissolution of Group: |
| |
Not Applicable
|
| |
|
Each
of the Reporting Persons makes the following certification:
By
signing below each Reporting Person certifies that, to the best of its knowledge and belief, the securities referred to above
were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer
of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that
purpose or effect. After reasonable inquiry and to the best of my knowledge and belief, the undersigned certify that the information
set forth in this statement is true, complete and correct.
| Date: July 14, 2022 |
|
Auctus Fund, LLC
By: Auctus Fund Management LLC, its Managing Member
By: /s/ Alfred Sollami
Name: Alfred Sollami
Title: Managing Member
Auctus Fund Management LLC
By: /s/ Alfred Sollami
Name: Alfred Sollami
Title: Managing Member
Alfred Sollami
By: /s/ Alfred Sollami
Name: Alfred Sollami
Title: Managing Member
Louis Posner
By: /s/ Louis Posner
Name: Louis Posner
Title: Managing Member
|
| CUSIP No. 090655606 | 13G | Page 7 of 8 Pages |
EXHIBIT A
Joint Filing Agreement Pursuant to Rule 13d-1
This agreement is made pursuant to Rule
13d-l(k)(1) under the Securities Exchange Act of 1934, as amended (the "Act") by and among the parties listed below,
each referenced to herein as a "Joint Filer". The Joint Filers agree that a statement of beneficial ownership as required
by Sections 13(g) or 13(d) of the Act and the rules thereunder may be filed on each of his, her or its behalf on Schedule 13G or
Schedule 13D, as appropriate, and that said joint filing may thereafter be amended by further joint filings. The Joint Filers state
that they each satisfy the requirements for making a joint filing under Rule 13d-1(k).
| Dated: July 14, 2022 |
| |
|
|
|
Auctus Fund, LLC
By: Auctus Fund Management LLC, its Managing Member
By: /s/ Alfred Sollami
Name: Alfred Sollami
Title: Managing Member
Auctus Fund Management LLC
By: /s/ Alfred Sollami
Name: Alfred Sollami
Title: Managing Member
Alfred Sollami
By: /s/ Alfred Sollami
Name: Alfred Sollami
Title: Managing Member
Louis Posner
By: /s/ Louis Posner
Name: Louis Posner
Title: Managing Member
|
| CUSIP No. 090655606 | 13G | Page 8 of 8 Pages |
BioRestorative Therapies (NASDAQ:BRTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
BioRestorative Therapies (NASDAQ:BRTX)
Historical Stock Chart
From Apr 2023 to Apr 2024
